Basecamp Wealth Advisors’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$696K Sell
4,311
-2,355
-35% -$392K 0.16% 66
2026
Q2
$1.26M Hold
6,666
– – 0.24% 48
2026
Q1
$1.31M Sell
6,666
-2
-0% -$386 0.27% 39
2025
Q4
$1.23M Buy
+6,668
New +$1.17M 0.26% 39

Other funds holding AZN

Basecamp Wealth Advisors's AZN Position: Q3 2026 in Review

Basecamp Wealth Advisors reduced its AstraZeneca (AZN) stake by 35% in Q3 2026, selling an estimated $392K and leaving 4,311 shares worth $696K. The position accounts for 0.16% of the portfolio, ranked #66.

Basecamp Wealth Advisors first reported a position in AZN in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.31M in Q1 2026. 1,429 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Basecamp Wealth Advisors held 4,311 shares of AstraZeneca worth $696K as of Q3 2026.
  • Basecamp Wealth Advisors sold 2,355 AstraZeneca shares in Q3 2026, an estimated $392K.
  • AstraZeneca made up 0.16% of Basecamp Wealth Advisors's portfolio in Q3 2026, its #66 holding.
  • Basecamp Wealth Advisors first reported a position in AstraZeneca in Q4 2025 and has held it in 4 quarters since.
  • Basecamp Wealth Advisors's AstraZeneca position peaked at $1.31M in Q1 2026.
  • 1,429 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.